ANTIFUNGAL PROPERTIES OF VARIOUS EXTRACTS OF BACILLUS SUBTILIS (TRACY STRAIN) OBTAINED IN THE BACITRACIN RECOVERY PROCESS*

Size: px
Start display at page:

Download "ANTIFUNGAL PROPERTIES OF VARIOUS EXTRACTS OF BACILLUS SUBTILIS (TRACY STRAIN) OBTAINED IN THE BACITRACIN RECOVERY PROCESS*"

Transcription

1 ANTIFUNGAL PROPERTIES OF VARIOUS EXTRACTS OF BACILLUS SUBTILIS (TRACY STRAIN) OBTAINED IN THE BACITRACIN RECOVERY PROCESS* MORRIS MOORE, PH.D.f AND WILFRED E. WOOLDRIDGE, M.D4 It has been known for some time that bacteria, either spore-formers or non-spore-formers are able to inhibit or alter the growth of a variety of bacteria and fungi. Many of the early papers on this subject have been reviewed by Waksman in a paper published in 1941 (1). Many other observations on antibiosis have never been published. The antibiotic activity of these bacteria was directed towards or observed on fungi which were either plant pathogens or saprophytes. In a report published in 1927, Weidman (2) remarked that he had noted several years previously that "portions of a certain ringworm fungus colony which were adjacent to a bacterial colony did not develop as luxuriantly as the more remote parts". The following year, Chambers and Weidman (3) while searching for organisms with "inhibitory properties against fungi" reported isolating bacteria from the normal toe webs of four patients. These bacteria were identified as Bacillus subtilis. They mixed bacterial colonies with 11 separate species of fungi. When the mixtures were cultured, they found that the bacteria completely inhibited the growth of the fungi. In their clinical work, they applied living organisms of Bacillus subtilis to toes affected with fungi and obtained up to 50 per cent improvement. While the senior author was working in in the mycological laboratory of Washington University, he noted that the stock cultures of pathogenic fungi planted on mediums made with shredded agar became overrun with a bacterium identified as Bacillus subtilis. The fungi were completely inhibited in growth and this was attributed to the bacterium which was later isolated in large numbers from the contaminated agar-agar. Tests made at a later date showed that this spore-forming bacillus was more resistant to sterilization than the usual, contaminating non-spore-forming bacteria. As to the finding of Bacillus subtilis in cultures for fungi, we have noted that when the bacterium is present in the skin scrapings, the growth of pathogenic fungi is invariably inhibited in the isolation medium. Bacillus subtilis is a fairly common contaminant of lesions of the toes, fingers and nails. In 1942, Katznelson (4) obtained a substance from an aerobic spore-forming bacillus which inhibited the growth of 71 out of 81 species of parasitic and saprophytic fungi, including also some gram-positive bacteria. The toxic substance was thermostabile and diffusible. In 1946, Lewis, Hopper and Shultz (5) reported the chance contamination of an experimental culture plate seeded with spores of Trichophyton mentagrophytes CI'. gypseum) and with Bacillus subtilis to determine the inhibiting action of the bacterium on the fungus. The inoculated B. subtilis had no effect on the fungus. The contaminant, however, later * From the Department of Dermatology of the Barnard Free Skin and Cancer Hospital and the School of Medicine, Washington University, St. Louis, Mo. Service of Richard S. Weiss, M.D. f Mycologist to the Barnard Free Skin and Cancer Hospital; the Barnes Hospital; and the Department of Dermatology, School of Medicine, Washington University. Research Assistant, Department of Dermatology, School of Medicine, Washington University and Assistant Dermatologist, the Barnard Free Skin and Cancer Hospital. This study was supported by a grant from the Commercial Solvents Corporation, New York City. Received July 27,

2 266 THE TOURNAL OF INVESTIGATIVE DERMATOLOGY identified as a variant of B. subtilis and named var. XG and XY, produced a definite zone of inhibition. A Seitz ifitrate of the bacterium contained the inhibitory principle which remained potent after 11 months storage on ice. These experiments with cultures of the living bacterium, Bacillus subtilis, and with the crude filtrates, demonstrated an inhibitory substance which was definitely able to arrest the growth of fungi as well as various species of gram-positive and gram-negative bacteria. With the development of the antibiotic penicillin in crystalline form and with the demonstration of its therapeutic possibilities, there was a sudden surge in an attempt to uncover new antibiotics. These new therapeutic agents were evolved from numerous fungi and bacteria and the list is growing steadily and rapidly. One of the most fruitful organisms for the production of different antibiotics is Bacillus subtilis. More inhibitory substances have been produced by this organism on a variety of mediums both inorganic and organic, with or without carbohydrates, than by any other known organism. Benedict and Langlykke (6) list five and possibly six antibiotics which have been crystallized. At the head of the list is subtitin, first described by Jansen and Hirschmann (7). This substance is active chiefly against gram-positive bacteria, mycobacteria and some pathogenic fungi (8). A second antibiotic, bacitracin, first described by Johnson, Anker and Meleney (9) was isolated from a strain ("Tracy 1") of Bacillus subtilis. It resembles subtilin in many ways but differs from it in that bacitracin is formed in the shallow layers of the medium, that is in the culture medium free of the cells and not in the submerged growth. Bacitracin is somewhat toxic but non-irritating to tissue, neutral, soluble in water and lower alcohols, relatively heat stable and resists digestion with trypsin or pepsin. It is active against grampositive organisms, gonococcus, meningococcus and some actinomycetes. Bacillin, a third antibiotic (anticoli factor) was reported by Foster and Woodruff (10). Carbohydrate appears to be essential in the medium for its production. It is highly active against gram-positive and gram-negative bacteria and is moderately toxic for mice. The antibacterial property of this antibiotic is reduced or eliminated when blood or other complex natural materials are present in the medium. Another antibiotic, eumycin, developed by the Marburg strain of Bacillus subtilis was reported by Johnson and Burdon (11). It is effective chiefly against Corynebacterium diphtheriae, Mycobacterium tuberculosis and some pathogenic fungi. It is ineffective against gram-negative bacteria and weakly effective against staphylococci. Strongly fungistatic fractions of eumycin are hemolytic and toxic for mice. The French workers have reported other antibiotics produced by Bacillus subtilis. These include subtilysin (subtilyne) reported by Vallée (12) which is effective against some gramnegative and gram-positive bacteria; endosubtilysin of Saint-Rat and Olivier (13) which was reported as nontoxie and effective in high dilution against staphylococci; and a third antibiotic named subtiline by Ramon and Richou (14). An antibiotic named licheniformin by Callow and D'Arcy Hart (15) and obtained from Bacillus licheniformis is considered to he identical with subtilin by Benedict and Langlykke with the organism probably identical with the Ford strain of Bacillus subtilis. In 1947, Landy, Rosenman and Warren (16) reported briefly on an antibiotic developed by Bacillus subtilis which had negligible antibacterial activity but was strongly effective against pathogenic fungi. The antibiotic was produced in shallow layers ins to 6 days, was heat stable, not inactivated in a hydrogen ion range of 2.5 to 9.0, non-dialyzable through cellophane membranes and was not inactivated by body fluids. In a later publication in 1948, Landy, Warren, Rosenman and Colio (17) named the antibiotic bacillomycin because of its high antifungal and low antibacterial activity. In 1948, also, Hirschhorn, Bucca and Thayer (18) reported an additional antibiotic from Bacillus subtilis which the authors named subtenolin because of its "strong enolic properties". Highest yields of the antibiotic were obtained in a medium containing dl-alanine, manganese and copper. Media containing carbohydrate, peptones and other complex organic enriching substances were poor producers of subtenolin. Subtenolin was active

3 PROPERTIES OF EXTRACTS OF BACILLUS SUBTILIS 267 against staphylococci, certain gram-positive and gram-negative bacteria and partially active against Mycobacterium tuberculosis and is toxic for mice inoculated peritoneally, the LD,0 being 30 to 60 mgm. (30,000 to 60,000 units). A study of the chemical properties of subtenolin by Howell and Tauber (19) showed that subtenolin differed chemically from streptomycin, penicillin G, gramicidin and bacitracin. It is apparent that Bacillus subtilis in crude form live whole cultures and the various antibiotics which it produces have a varying degree of antifungal activity. In a search for an agent which would be strongly effective against pathogenic fungi, it was felt that an attempt should be made to obtain, in pure form, the antifungal property from Bacillus subtilis. Of the known antibiotics, at the time the study was undertaken, bacitracin was not only made available in sufficient quantity but the various fractions used in the study were also prepared through the courtesy of the Commercial Solvents Corporation. This paper, therefore, is devoted to a study of the antifungal properties of Bacillus subtilis, of bacitracin, an antibiotic produced by the organism and of the various fractions derived during and after the process involved in the extraction of bacitracin. MATERIALS AND TECHNIC In the evaluation of the antifungal properties of Bacillus subtilis, cultures of living bacilli as well as various extracts obtained from the organism and from the medium in which the organism was grown were used. The strains of Bacillus subtilis employed were the Tracy I strain which yields the antibiotic bacitracin and a strain obtained from the Western Regional Research Laboratories, culture number 370, which produces the antibiotic subtilin. A third strain obtained from the Venereal Disease Research Laboratory at Staten Island, New York, culture number 370, apparently was identical with the strain from the Western Regional Research Laboratory. In experiments with the live organisms, plates seeded with the various pathogenic fungi were inoculated at several points in the plates to determine the inhibitory effect of the bacillus on the fungus. Sabouraud's glucose agar or broth (Difco) was used throughout this work. A number of filtrates were also employed. These include a crude broth filtrate containing live cells, the lyophilized crude broth filtrate which was cell free and several filtrates obtained prior to and following the recovery of bacitracin. These may be best demonstrated in the accompanying schematic fiowsheet indicating the processes involved in the recovery of bacitracin. The organisms used for investigation in this paper were selected because of their common occurrence (producers of superficial dermatomycoses and of the invasive or systemic mycoses) and because of their ability to grow well. Unfortunately, in most instances, the amount of material available for use was insufficient in quantity, due to production difficulties, to warrant the use of a large number of different species of pathogenic fungi. Because of these circumstances, it was felt that the proper selection of a sufficiently representative number of species of fungi, well controlled, although small in number, would

4 268 'E JOURNAL OF INVESTIGATIVE DERMATOLOGY best evaluate the extract or fraction tested. To avoid needless repetition, the fungi used are listed in the tables, with the results. Whole culture experiments. In this series, plates seeded with suspensions of various fungi were inoculated with the strains of Bacillus subtilis. All cultures of fungi were, with the exception of Histoplasma capsulatum, nine days old. H. capsulatum was 26 days old. The cultures of B. subtilis were three to four days old. The inoculated plates were incubated at room temperature, approximately 25 C. and the final readings and photographs were made 17 days after inoculation (Fig. 1). This is a crude but significant form of experiment since it gives some clue as to the susceptibility of the fungi to the antifungal principle which is elaborated by the bacterium in its growth processes. To be sure, we are not dealing with Whole Collate (Breillos Sebtillo) Satv.nt A Grad. Broth Filtrate Ole. Cello) LyophiIled Grade Broth Filtrate Cell Free) Sport Boor Filtrate B l.oyer Spool Solvent A Filtrate C flltrote E I_Solvent Loper Spent Water Layer FiltrateD Loy.r Water l.ayer (Bocltroeltt) Filtrate F SCHEMATIC FLOWSNEET OF FII..TRATE RECOVERY a purified agent but a complex substance made up of several impure reactors. Consequently, it was hoped that should there be any inhibition of the fungi with the living organisms then better results should be expected with purified principles. Plates observed 17 days after inoculation revealed that in most instances Bacillus subtilis had grown rather widely due perhaps to the fact that the medium was fresh and that there was considerable moisture on the agar surface. The results, however, could be interpreted without difficulty. The yeastlike organisms, Cryptococcus neoformans, Monilia (Candida, Syringospora) albicans (Fig. 1, 4) and Sporotrichum schenckii were not affected by the bacterium, showing an unrestrained growth and in some plates overgrowth of the bacterial colonies. The dermatophytes, however, including Microsporum canis (Fig. 1, 1) M. gypseum (M. fulvum), Trichophyton mentagrophytes (Fig. 1, 2), Achorion

5 PROPERTIES OF EXTRACTS OF BACiLLUS SUBTILIS 269 Fin inoculated at three poiots with Bacillus subtilis and photographed 17 days after inoculation; 5 6 inoculated at one point with B. suhtilis aod photographed 9 days after inoculation. All grown on Sabouraud's (Difco) glucose agar. I. Microsporum canis; 2. Trichophton mentagrophytes; 3. Coccidioides immitis; 4. Monilia (Candida) albicans; 5. Nocardia asteroides; 6. N. brasiliensis. schoenleinii and Epidermophyton fioccosum exhibited definite zones of inhibition. This inhibitory effect Could also be clearly demonstrated with some of the fungi causing systemic mycoses. The chief systemic invaders affected were

6 270 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY Coccidioides immitis (Fig. 1, 3) and the aerobic actinomycetes, Nocardia asteroides (Fig. 1, 5), N. madurae and N. brasiliensis (Fig. 1, 6). The Nocardias showed the widest zones of clearing with the best zone evident in plates seeded with N. brasiliensis. With other systemic fungi, Zymonema (Blastomyc es) dermatitidis and Histoplasma capsulatum, there was definite evidence of retardation of the fungus growth. The results obtained with this crude experiment indicated that better results were to he expected with more specific fractions or extracts especially with the dermatophytes and the Nocardias and to some extent with the systemic fungi but not with the yeastlike organisms. The following experiments were carried out with the various substances, extracts or filtrates as shown in the flow sheet. Crude broth filtrate. This filtrate contained living bacterial cells and as such was consistently producing an active principle. With the small supply of material available, only two organisms were tested, Trichophyton mentagrophytes and Coccidioides immitis. Serial dilutions were made as shown in Table 1. T. ORGANISMS Trichophyton mentagrophytes... Coccidioides immitis TABLE 1 Crude broth filtrate Results read 32 days after inoculation. Trichophyton mentagrophytes was inhibited in dilutions up to 1:50 whereas Coceidioides immitis showed inhibition in dilutions up to 1:250. mentagrophytes showed growth in a dilution of 1:50 and C. immitis in a dilution of 1:250 after 32 days. This experiment was analogous to the use of living organisms. The results coincided roughly with the zones of inhibition produced in the plate cultures but here, a more accurate or quantitative determination could be made of the activity of the antibiotic. Lyophitized crude broth filtrate. This was a lyophilized filtrate of the crude broth and was cell free. Serial dilutions corresponded to those with the crude broth filtrate. The results arc shown in Table 2. Readings were made 20 days after inoculation. T. mentagrophytes and C. immitis were inhibited in a dilution of 1:50 and showed growth in a dilution of 1: 100. The dermatophytes, Microsporum canis, M. gypseum, Epidermophyton fioccosum and Achorion schoenleinii were inhibited in a dilution of 1:100 but grew in a dilution of 1:250. Monilia albicans was unaffected, growing in all dilutions. Cryptococcus neoformans and Sporotrichum schenckii were inhibited through a dilution of 1:20 but grew in 1:50. Zymonema dermatitidis and Histoplasma capsulatum were similar in their response. The best inhibition was exhibited by Nocardia asteroides showing growth in a dilution of 1:500 with no growth in 1:250. Filtrate A. This filtrate represents the original filtered beer. Three organisms Control + +

7 PROPERTIES OF EXTRACTS OF BACILLUS SUBTILIS 271 were used in this experiment because of the small amount of material available. As seen in Table 3, only N. asteroides was inhibited and in a concentration of 1:1,000 with growth in the next dilution 1:10,000. Both C. immitis and T. mentagrophytes were not inhibited. O1GASMS TABLE 2 Lyophilized crude broth filtrate 1:1 1:5 1:10 1:20 1:50 1:100 1:250 1:500 1:750 1:1,000 Microsporum canis Microsporum gypseum Trichophyton mentagrophytes... + Achorion schoenleinii Epidermophyton floccosum Monilia albicans Sporotrichum schenckii Nocardia asteroides Histoplasma capsulatum Cryptococcus neoformans Zymonema dermatitidis Coccidioides immitis Results read 20 days after inoculation. Monilia albicans grew in all dilutions. Sporotrichum schenckii, Histoplasma capsulatum, Cryptococcus neoformans and Zymonema dermatitidis grew in dilutions of 1:50 and greater. Trichophyton mentagrophytes and Coccidioides iinrnitis were inhibited in dilutions up to 1:100. Microsporum canis, M. gypscum, Achorion schoenleinii and Epidermophyton fioccosum were inhibited in a dilution of 1:100 with growth in dilutions of 1:250 and higher. Nocardia asteroides showed best results, being inhibited in dilutions up to 1:500 with growth in dilutions of 1:500 and higher. ORGANISMS Trichophyton mentagrophytes.. Nocardia asteroides Coccidioides immitis TABLE 3 Filtrate A :50 1:100 1:250 1:500 1:1,000 1:10,000 1:100,000 Control Results read 16 days after inoculation. Trichophyton mentagrophytes and Coccidioides immitis were not inhibited in any dilution. Nocardia asteroides was inhibited in dilutions of 1:1,000 with growth in dilutions of 1:10,000 and higher. Filtrate B. This filtrate consists of the so-called spent beer following solvent extraction. In addition to the organisms tested with filtrate A, the fungi Monilia albicans, Sporotrichum schenckii and Zymonema dermatitidis were used. All of the organisms were completely uninhibited with the exception of N. asteroides

8 272 TEE JOURNAL OF INVESTIGATIVE DERMATOLOGY which showed pronounced inhibition in a dilution of 1:10,000 with growth in the next dilution, 1:100,000 appearing after 20 days. It was apparent that the antibiotic became completely spent sometime after the sixteenth day since there was inhibition up until that time in 1:100,000, as seen in Table 4. ORGANISMS TABLE 4 Filtrate B 1:50 1:100 1:250 1:500 1:1,000 1:10,000 1:100,000 Control Trichophyton mentagrophytes Monilia albicans + Sporotrichum schenckii Nocardia asteroides Zymonema dermatitidis Coccidioides immitis Results read 16 and 20 days after inoculation. indicates no growth at 16 days but growth at 20 days. All the organisms with the exception of Nocardia asteroides grew in all the dilutions, some showing delayed growth. N. asteroides showed pronounced inhibition in a dilution of 1:10,000 with delayed growth (after20 days) in a dilution of 1:100,000. ORGANISMS 1:50 TABLE 5 Filtrate C 1:100 Microsporum canis Trichophyton mentagrophytes Nocardia asteroides Cryptococcus neoformans + + Zymonema dermatitidis Coccidioides immitis :250 1:500 1:1,000 1:10,000 1:100,000 Control Results read 17 days after inoculation. Microsporum canis, Trichophyton mentagrophytes and Coccidioides immitis were uninhibited in all dilutions. Cryptococcus neoformans grew in dilutions of 1:500 and higher. Zymonema dermatitidis was inhibited in a dilution of 1:1,000 and Nocardia asteroides in a dilution of 1:10,000. Filtrate C. This filtrate represents the spent solvents. M. canis, T. mentagrophytes and C. immitis were uninhibited. C. neoformans was inhibited in a dilution of 1:250, Z. dermatitidis in a dilution of 1:1,000 and N. asteroides in a dilution of 1:10,000. The results as shown in Table 5 were read 17 days after inoculation. Apparently the fungicidal principle resides in the spent solvents and is not affected by the extraction process. Filtrate D. This filtrate represents the first water extraction from the second

9 PROPERTIES OF EXTRACTS OF BACILLUS SUBTILIS 273 solvent extraction. This filtrate was extracted from filtrate C. As seen in Table 6, T. mentagrophytes and C. immitis were not inhibited whereas N. asteroides was inhibited in a dilution of 1:10,000 after 16 days. ORGANISMS Trichophytonmentagrophytes.. Nocardia asteroides Coccidioides immitis TABLE 6 Filtrate D :50 1:100 1:250 1:500 1:1,000 1:10,000 1:100,000 Control Results read 16 days after inoculation. Trichophyton mentagrophytes and Coccidioides immitis were not inhibited whereas Nocardia asteroides was inhibited through a dilution of 1:10,000. TABLE 7 Filtrate E 1:20 1:40 1:80 1:200 1:1,000 1:10,000 1:100,000 Control ORGANISMS Microsporum canis + + Microsporum gypseum Trichophyton mentagrophytes. + Achorion schoenleinii + Epidermophyton floccosum + Monilia albicans + Sporotrichum schenckii Nocardia asteroides + Nocardiamadurae + Nocardia brasiliensis Histoplasma capsulatum Cryptococcus neoformans Zymonema dermatitidis Results read 16 and 20 days after inoculation. F indicates no growth at 16 days but Coccidioides immitis + growth at 20 days. Microsporum gypseum, Trichophyton mentagrophytes, Monilia albicans, Sporotrichum schenckii and Cryptococcus neoformans were not inhibited. Micro. sporum canis and Coccidioides iminitis grew, after 20 days, in a dilution of 1:40. Achorion schoenleinii grew, after 20 days, in a dilution of 1:80. Epidermophyton floccosum and Histoplasma capsulatum grew, after 16 days, in a dilution of 1:200 whereas Zymonema dermatitidis grew in the same dilution after 20 days. Nocardia asteroides and N. madurae grew, after 20 days, in a dilution of 1:100,000 but N. braciliensis was not inhibited in 1:100,000. Filtrate E. This filtrate is composed of the water extract of the spent solvents (filtrate C) from the bacitracin recovery process. Twelve organisms were used in this experiment as listed in Table 7. The results were read 16 and 20 days following inoculation. M. gypseum, T. mentagrophytes, M. albicans, S. schenckii

10 274 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY and C. neoformans were not inhibited. M. canis and C. immitis were inhibited in a dilution of 1:40 after 16 days with growth apparent in this dilution after 20 days. A. schoenleinii was inhibited in a dilution of 1:80 after 16 days with growth evident in this dilution after 20 days. E. fioccosum, H. capsulatum and Z. dermatitidis were inhibited in a dilution of 1:80 with growth in the next dilution 1: 200. With Z. dermatitidis growth occurred in this dilution after 20 days. The actinomycetes, N. asteroides, N. madurae and N. brasiliensis showed inhibition in dilutions up to and including 1:100,000. N. asteroides and N. madurae, however, showed slight growth in this dilution after 20 days. TABLE 8 Filtrate F DILUTZONS O2OANXSMS C Trichophyton mentagrophytes Moniliaalbicans Sporotrichum schenckii Nocardia asteroides.... Nocardia madurae Nocardia brasiliensis... Zymonema dermatitidis. Coccidioides immitis C Control. Results read 14 days after inoculation. Trichophyton mentagrophytes, Monilia albicans, Sporotrichum schenckii, Zymonema dermatitidis and Coccidioides immitis were not inhibited in any dilution. Nocardia asteroides and N. Madurae showed inhibition in a dilution of 1:10,000 with growth in 1:50,000. N. brasiliensis showedinhibition inl:750,000 with growth in a dilution of 1:1,000,000. Filtrate F. This filtrate is bacitracin. Eight organisms were employed as seen in Table 8. The species specificity of this extract was well demonstrated by the fact that T. mentagrophytes, M. albicans, S. schenckii, Z. dermatitidis and C. inunitis were unaffected whereas N. asteroides and N. madurae were inhibited by a dilution of 1:10,000 with growth in a dilution of 1: 50,000. N. brasiliensis was inhibited in a dilution of 1:750,000 with growth occurring in a dilution of 1:1,000,000. Readings were made after 14 days. Filtrate G. This filtrate represents the solvents following the second extraction. Five organisms were utilized as listed in Table 9. Again, T. mentagrophytes and C. immitis were uninhibited. N. asteroides and N. madurae were inhibited in dilutions of 1:10,000 with growth in a dilution of 1:25,000. N. brasiliensis again showed the best inhibition with no growth in a dilution of 1:250,000 and growth in a dilution of 1:500,000. The results were read 14 and 17 days after inoculation.

11 PROPERTIES OF EXTRACTS OF BACILLUS SUBTILIS 275 Filtrate H. This filtrate represents the material following the second extraction as found in the water layer. The same organisms were used here as with filtrate G. Final readings were made 17 days following inoculation. T. men- ORGANISMS TABLE 9 Filtrate G r g. Trichophyton mentagrophytes Nocardia asteroides Nocardia madurae Nocardia brasiliensis Coccidioides immitis Results read 14 days after inoculation. Trichophyton mentagrophytes and Coccidioides immitis were uninhibited. Nocardia asteroides and N. xnadurae were inhibited in dilutions of 1:10,000 with growth in a dilution of 1:25,000. N. brasiliensis grew in a dilution of 1:500,- 000 with inhibition in 1:250,000. TABLE 10 Filtrate H ORGAOSMS o 8-9 ',c a 9 0 9e 9 ' X, 9 - Trichophyton mentagrophytes Nocardia asteroides... + Nocardia madurae Nocardia brasiliensis... Coccidioides immitis :10 1:1,000,000. 1:1.5 X 10 = 1:1,500,000. C Control. Results read 17 days after inoculation. Trichophyton mentagrophytes and Coccidioides immitis showed inhibition in a dilution of 1:250 with growth in 1:500. Nocardia asteroides and N. madurae were inhibited in a dilution of 1:10,000 with growth in 1:25,000. N. brasiliensis was inhibited in a dilution of 1:1,000,000 with growth in 1:1,500,000. tagrophytes and C. immitis were inhibited in a dilution of 1:250 with growth occurring in a dilution of 1: 500. N. asteroides and N. madurae were inhibited in a dilution of 1:10,000 with growth occurring in a dilution of 1:25,000. N. brasiliensis showed inhibition in a dilution of 1:4,000,000 for 11 days but showed inhibition only through a 1:1,000,000 dilution after 14 days where it remained

12 276 THE JOURNAL OF INVESTIGATiVE DERMATOLOGY after 17 days. There is a definite specificity for N. brasiliensis with this filtrate. The results are shown in Table 10. Additional experiments. In addition to testing the various filtrates, an experiment was set up to include bacitracin in the medium in various concentrations with the addition of 50 per cent human serum. The single organism N. asteroides was used. Readings made 14 days after inoculation showed inhibition in a dilution of 1:10,000 with growth in the next dilution (1: 25,000). Apparently, the serum did not exert any influence on the inhibition or growth of the fungus. TABLE 11 Bacitracin renewal experiment OROANI5ISS Nocardia asteroides Nocardia madurae Nocardia brasiliensis 15 days 15 days 15 days 1:10,000 1:25,000 1:50,000 1:75,000 1:100,000 1:200, :500, :750, :1,000, :1,500, :2,000, :2,500, :3,000, :4,000, :5,000, Control per cent of original concentration of bacitracin added on fifth and tenth day following inoculation. Results read 15 days following inoculation. Nocardia asteroides showed inhibition in a dilution of 1:100,000. N. madurae was inhibited in a dilution of 1:1,000,000 with growth in 1:1,500,000. N. brasiliensis was inhibited in a dilution of 1:2,500,000 with growth in 1:3,000,000. A second additional experiment consisted of renewing the bacitracin in the medium on the fifth and tenth day following inoculation. The bacitracin was originally added to the medium in varying concentrations. On the fifth and tenth day respectively, 25 per cent of the original concentration was added on the basis that bacitracin loses that much of its potency on standing in an aqueous solution. Readings were made on the fifteenth day following inoculation. The three Nocardias were employed. N. asteroides was inhibited in a dilution of 1:100,000 with growth in a dilution of 1:200,000. N. madurae was inhibited in a dilution of 1:1,000,000 with growth in a dilution of 1:1,500,000. N. brasiliensis was inhibited in a dilution of 1:2,500,000 with growth occurring in a dilution of 1:3,000,000. The results when compared with those of the other experiments,

13 PROPERTIES OF EXTRACTS OF BACILLUS SUBTILIS 277 including the various filtrates of the bacitracin recovery process and with bacitracin itself, support the contention that bacitracin is weakened in an aqueous solution and that renewal of the antibiotic is essential for it to exert its optimum antibiotic activity. DISCUSSION It is apparent from the literature that various strains of Bacillus subtilis extracted by different methods, may give rise to antibiotics with a varied antifungal spectrum. A review of the several reported antibiotics with such capabilities clearly demonstrates this. Katznelson (4) used chiefly plant pathogens and a few aerobic actinomycetes. He found that Nocardia asteroides grew poorly in a concentration of 60 per cent by volume and not at all in a concentration of 80 per cent by volume. Salle and Jann (8) worked with subtilin and found several Nocardias, including N. asteroides, to be inhibited by a concentration of 1: 1,000 whereas nonsusceptible organisms included Monilia albicans, Cryptococcus neoformans, Sporotrichum schenckii and Trichophyton mentagrophytes. Lewis, Hopper and Shultz (5) incorporated culture filtrates in medium and were able to inhibit T. mentagrophytes in a dilution of 1:100. Microsporum gypseum was inhibited in a dilution of 1:20, Monilia alibicans in a dilution of 1:10 and Sporotrichum schenckii in a dilution of 1:20. Johnson and Burdon (11) found that eumycin in a concentration of 0.1 to 0.3 mgm. (dry weight) per ml. of medium prevented entirely or definitely inhibited the growth of Trichophyton mentagrophytes, Microsporum gypseum, Epidermophyton fioccosum and related species of fungi, including Nocardia. The effect of eumycin was slightly less on Sporotrichum schenckii and Hormodendrum and it had no effect on Monilia albicans or Cryptococcus neoformans. The best antifungal spectrum with a Bacillus subtilis antibiotic was that obtained by Landy, Warren, Rosenman and Colio who employed bacillomycin. The dermatophytes including Microsporum audouini, M. gypseum, Trichophyton mentagrophytes, T. rubrum, Epidermophyton fioccosum and Achorion schoenleinii were inhibited in a dilution of mgm. bacillomycin per ml. of medium or a dilution of 1:75,000. Of the more invasive fungi, Coccidioides immitis, Histoplasma capsulatum, Monosporium apiospermum and Paracoccidioides braziliensis were also inhibited in the same concentration (0.025 mgm. bacillomycin per ml. medium). The mycelial form of Zymonema dermatitidis was inhibited in a concentration of mgm. bacillomycin per ml. medium or 1:100,000 dilution, whereas the yeast form of the fungus was more resistant being inhibited in a dilution of mgm. bacillomycin per ml. medium or a dilution of 1:750,000. Monilia albicans, Cryptococcus neoformans and Sporotrichum schenckii were inhibited in a dilution of 0.05 mgm. bacillomycin per ml. medium or a dilution of 1:50,000. On the other hand, Phialophora verrucosa, P. pedrosoi and Nocardia asteroides were not inhibited in a dilution as low as 0.5 mgm. bacillomycin per ml. medium or a dilution of 1:5,000. In sharp contrast to bacillomycin which had no effect on Nocardia, bacitracin,

14 278 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY the antibiotic obtained from the Tracy strain of Bacillus subtilis shows a strongly inhibitory action on Nocardia asteroides, N. madurae and N. brasiliensis (Table 8). The former two are inhibited in a dilution of 1:10,000 while the latter is prevented from growing in a dilution of 1: 750,000. The fungi T. mentagrophytes, M. albicans, S. schenckii, Z. dermatitidis and C. immitis, again in sharp contrast are not inhibited by bacitracin in a dilution as low as 1:50. It is apparent that the antifungal property of this strain of Bacillus subtilis is lost or destroyed with some of the filtrates and altered with others as compared with the antifungal activity elicited when the crude filtrates with or without living organism are used. In filtrates A, B, C, D, F (bacitracin) and G, the antibiotic activity is limited to the Nocardias with only Z. dermatitidis being inhibited in a dilution of 1:1,000 by filtrate C whereas in filtrates E and H there is some activity against other pathogenic fungi, with the best results being obtained with filtrate H. T. mentagrophytes and C. immitis are inhibited in a dilution of 1:250 by filtrate H. The inhibition of the aerobic Actinomycetes (Nocardias) varies with the different filtrates. N. asteroides is inhibited by filtrate A in a dilution of 1: 1,000 and in a dilution of 1:10,000 by filtrates B, C, D, E, F, G and H. N. madurae likewise is inhibited in a dilution of 1:10,000 by filtrates E, F, G and H. N. brasiliensis on the other hand appears to be most susceptible to the various filtrates being inhibited in a dilution of 1:100,000 by filtrate E, 1: 750,000 by filtrate F, 1:250,000 by filtrate G and 1: 1,000,000 by filtrate H. In comparing the three Nocardias it would appear that N. braziliensis is a very unstable organism as contrasted with the stable inhibitory responses of N. asteroides and N. madurae to the various filtrates. In the presence of human serum (50 per cent in Sabouraud's broth), N. asteroides was inhibited in a dilution of 1:10,000 bacitracin. The serum apparently had no effect on the bacitracin. The best results obviously were obtained with the bacitracin renewal experiment. Twenty-five per cent of the original concentration of bacitracin was added on the fifth and tenth day following inoculation. The results read on the fifteenth day following inoculation showed that N. asteroides was inhibited in a dilution of 1:100,000, ten times the inhibition found in the various filtrates. N. madurae was inhibited in a dilution of 1:1,000,000, one hundred times the inhibition found in the filtrates. N. brasiliensis was inhibited in a dilution of 1:2,500,000 which is considerably greater than that obtained with the filtrates. It may be concluded from the evidence in the literature and from the results obtained here that in the field of medical mycology, the antibiotics derived from Bacillus subtilis are chiefly effective against the aerobic Actinomycetes. Two antibiotics, however, that obtained from the Marburg strain and named eumycin and that named bacillomycin, show activity against other fungi. In sharp contrast, bacillomycin is strongly active against many of the pathogenic fungi but is relatively inactive against the Nocardias. Bacitracin is strongly active against the Nocardias but relatively inactive against other pathogenic fungi.

15 PROPERTIES OF EXTRACTS OF BACILLUS SUBTILIS 279 Evidence is accumulating, as a result of the examination of material from numerous pulmonary cases suspected of being tuberculosis, that mycoses due to Nocardia asteroides are more frequent than is commonly suspected. In the past few months, five cases with lung disease and one with endocarditis, all caused by N. asteroides as proven by cultures, have been so diagnosed by the senior author. In such cases the use of bacitracin could have been of great value. Unfortunately, bacitracin is not yet available commercially for injection purposes. The antibiotic, however, has been tested experimentally in humans and it has been found that intramuscular injections of bacitracin may be given in doses of 10,000 units or larger every four to six hours. There may be a local reaction at the site of injection which can be lessened by combining procaine or novocaine with the injected antibiotic. Patients who have received newer preparations of bacitracin by injection over a long period of time have exhibited minimal toxic symptoms. These patients had to be watched particularly for albuminuria. Some patients with bacterial infections resistant to penicillin and streptomycin have tolerated large amounts of bacitracin by injection with beneficial results. Work is progressing at the present time on the preparation of a purer and less toxic supply of bacitracin. SUM?VIABY In an attempt to find an antibiotic active against pathogenic fungi, various filtrates of the Bacillus subtilis (Tracy strain) were employed. These consisted of whole cultures (living cells), crude broth filtrates (live cells), lyophilized crude broth filtrate (cell free) and the several filtrates obtained in the bacitracin recovery process. The crude filtrates, including the whole culture, exerted an inhibitory action on the fungi used. This was not apparent in dilutions greater than 1:250 with the crude filtrates, either with or without living cells. Some of the fungi were inhibited in dilutions no greater than 1:20, others in dilutions no greater than 1:50 or 1:100. Various filtrates developed in the bacitracin recovery process were employed in order to determine whether such filtrates might possibly contain antifungal properties. These consisted of eight filtrates labelled in the order in which they were formed in the recovery process. Filtrates A and B exerted an action only on Nocardia asteroides in dilutions of 1: 1,000 and 1: 10,000 respectively. Filtrate o had antifungal properties for Cryptococcus neoformans (1:250), Zymonema dermatitidis (1:1,000) and Nocardia asteroides (1:10,000). Filtrate D also affected Nocardia asteroides (1:10,000 dilution). Filtrate E had mild antibiotic activity for Microsporum canis (1:20), Achorion schoenleinii (1:40), Epidermophyton fioccosum (1:80), Histoplasma capsulatum (1:80), Zymonema dermatitidis (1:80) and Coccidioides imxnitis (1:20). Antibiotic activity was manifest with the Nocardias: N. asteroides (1:10,000; N. madurae (1: 10,000); and N. brasiliensis (1:100,000). Filtrate F showed antibiotic activity only with the Nocardias: N. asteroides (1:10,000); N. madurae (1:10,000); and N. brasiliensis (1:750,000). Filtrate G likewise showed activity only against the Nocardias:

16 280 THE JOIJRNAL OF INVESTIGATIVE DERMATOLOGY N. asteroides (1: 10,000); N. madurae (1: 10,000); N. brasiliensis (1: 250,000). Filtrate H showed mild activity against Trichophyton mentagrophytes (1:250), Coccidioides immitis (1:250) but strong activity against the Nocardias: N. asteroides (1:10,000); N. madurae (1:10,000); and N. brasiliensis (1: 1,000,000). With all the filtrates the activity against N. asteroides and N. madurae remained constant (1:10,000) whereas against N. brasiliensis the activity ranged from 1:100,000 through 1: 1,000,000. The addition of 50 per cent human serum to the test medium did not alter the activity of bacitracin against N. asteroides. The best results were obtained by the renewal of the bacitracin in the amount of 25 per cent of the original concentration added to the medium on the fifth and tenth day following inoculation. After 15 days, N. asteroides was inhibited in a dilution of 1:100,000, N. madurae in a dilution of 1:1,000,000 and N. brasiliensis in a dilution of 1: 2,500,000. Bacitracin and the various filtrates produced in the recovery process, therefore, are mildly active to inactive against most pathogenic fungi and strongly active against the Nocardias. REFERENCES 1. WAXSMAN, S. A.: Antagonistic relations of microorganisms. Bact. Revs. 5: (Sept.) WEIDMAN, F. D.: Laboratory aspects of epidermophytosis. Arch. IDermat. & Syph. 15: (April) CHAMBERS, S., AND WEIDMAN, F. D.: A fungistatic strain of Bacillus subtilis isolated from normal toes. Arch. Dermat. & Syph. 18: (Oct.) KATZNELSON, H.: Inhibition of microorganisms by a toxic substance produced by an aerobic spore-forming bacillus. Canadian J. Res., Sect. C, 20: 169 (March) LEwis, G. M., HOPPER, M. E., AND SHULTZ, S.: In vitro fungistasis by a bacterium (Bacillus subtilis var. XG and XY). Arch. Dermat. & Syph. 54: (Sept.) BENEDICT, R. G., AND LANGLYKKE, A. F.: Antibiotics. Ann. Rev. Microbiol. 1: , JANSEN, E. F., AND HIRSCHMANN, D. J.: Subtilin An antibacterial product of Bacillus subtilis. Culturing conditions and properties. Arch. Biochem. 4: (July) SALLE, A. J., AND JANN, G. J.: Subtilin An antibiotic produced by Bacillus subtilis. I. Action on various organisms. Proc. Soc. Exper. Biol. & Med. 60: 60 64, JOHNSON, B. A., ANKER, N., AND MELENEY, F. L.: Bacitracin; A new antibiotic produced by a member of the B. subtilis group. Science 102: 376 (Oct. 12) FOSTER, J. W., AND WOODRUFF, H. B.: Bacillin, a new antibiotic substance from a soil isolate of Bacillus subtilis. J. Bact. 51: , JOHNSON, E. A., AND BURDON, K. L.: Eumycin A new antibiotic active against pathogenic fungi and higher bacteria, including bacilli of tuberculosis and diphtheria. J. Bact. 51: 591, VALLEE, M.: Etude du pouvoir Bactériolytique de Bacillus subtilis. Compt. rend. Soc. Biol. 139: , SAINT-RAT, L. DR, ET OLIvIER, H. R.: Extraction et purification de L'endosubtilysine. Compt. rend. 222: , RAMON, G., ET Ricriou, R.: De l'infiuence sur les propriétés antibiotiques et antidotiques des filtrats de culture du B. subtilis, de Ia chaleur et de l'aldehyde formique agissant simultanément. Compt. rend. 222: , 1946.

17 PROPERTIES OF EXTRACTS OF BACILLUS SUBTILIS CALLOW, R. K., AND D'ARcr HART, P.: Antibiotic material from Bacillus licheniformis (Weigmann emend. Gibson) active against species of Mycobacteria. Nature 157: , LANDY, M., ROSENMAN, S. B., AND WARREN, G. H.: An antibiotic from Bacillus subtilis active against pathogenic fungi. J. Bact. 54: 24 (July) LANDY, M., WARREN, G. H., ROSENMAN, S. B., AND CoLlo, L. G.: Bacillomycin: An antibiotic from Bacillus subtilis active against pathogenic fungi. Proc. Soc. Exper. Biol. & Med. 67: (April) HIRSOHHORN, H. N., BUCCA, M. A., AND THAYER, J. D,: Subtenolin: An antibiotic from Bacillus subtilis. I. Bacteriologic properties. Proc. Soc. Exper. Biol. & Med. 67: (April) HOWELL, S. F., AND TAURER, H.: Subtenolin. An antibiotic from Bacillus subtilis. II. Isolation and chemical properties. Proc. Soc. Exper. Biol. & Med. 67: (April) 1948.

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE Pharm 262: 1 Pharmaceutical Microbiology II Antibiotics DR. C. AGYARE Reference Books 2 HUGO, W.B., RUSSELL, A.D. Pharmaceutical Microbiology. 6 th Ed. Malden, MA: Blackwell Science, 1998. WALSH, G. Biopharmaceuticals:

More information

Occurrence of Dermatophytes in Fresh Bat Guano1

Occurrence of Dermatophytes in Fresh Bat Guano1 APPLIED MICROBIOLOGY, Sept., 1965 Copyright ) 1965 American Society for Microbiology Vol. 13, No. 5 Printed in U.S.A. Occurrence of Dermatophytes in Fresh Bat Guano1 EDWIN S. KAJIHIRO Department of Biology,

More information

Fungal Disease. What is a fungus?

Fungal Disease. What is a fungus? Fungal Disease What is a fungus? A fungus is a living organism. It goes through a complicated life cycle and is able to spread in the environment by producing large numbers of spores that are easily dispersed

More information

Burn Infection & Laboratory Diagnosis

Burn Infection & Laboratory Diagnosis Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die

More information

DO NOT WRITE ON or THROW AWAY THIS PAPER!

DO NOT WRITE ON or THROW AWAY THIS PAPER! What Kills Bacteria? Lab Procedure Go to the following link: http://www.glencoe.com/sites/common_assets/science/virtual_labs/ls08/ls08.html or DO NOT WRITE ON or THROW AWAY THIS PAPER! Visit my eboard

More information

SENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS

SENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS Thorax (195), 5, 162. THE BEHAVIOUR OF MIXTURES OF STREPTOMYCIN- SENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS BY D. A. MITCHISON* From the Department of Bacteriology, Postgraduate

More information

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only USA Product Label http://www.vetdepot.com PHARMACIA & UPJOHN COMPANY Division of Pfizer Inc. Distributed by PFIZER INC. 235 E. 42ND ST., NEW YORK, NY, 10017 Telephone: 269-833-4000 Fax: 616-833-4077 Customer

More information

loopfull is removed from each dilution and transferred to capable of killing the test organism in 10 minutes but not GERMICIDAL SUBSTANCES

loopfull is removed from each dilution and transferred to capable of killing the test organism in 10 minutes but not GERMICIDAL SUBSTANCES A NEW METHOD FOR THE EVALUATION OF GERMICIDAL SUBSTANCES A. J. SALLE, W. A. McOMIE AND I. L. SHECHMEISTER Department of Bacteriology, University of California, Berkeley, California Received for publication

More information

BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA*

BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA* Brit. J. Ophthal. (1954), 38, 719. BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA* BY C. H. SMITH Department of Pathology, Institute of Ophthalmology, University of London THE normal bacterial flora of the mucous

More information

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection. 1. NAME OF THE MEDICINAL PRODUCT Nystimex, 100 000 IU/ml oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 000 IU nystatin. Excipients: Methyl parahydroxybenzoate 1 mg Sodium

More information

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test EXPERIMENT Antibiotic Sensitivity-Kirby Bauer Diffusion Test Author Name Version 42-0238-00-02 Review the safety materials and wear goggles when working with chemicals. Read the entire exercise before

More information

Klett-Summerson photoelectric colorimeter. The presence of the glucose RESISTANCE AND SYNERGISM IN STREPTOMYCIN

Klett-Summerson photoelectric colorimeter. The presence of the glucose RESISTANCE AND SYNERGISM IN STREPTOMYCIN THE CORRELATION BETWEEN THE INHIBITION OF DRUG RESISTANCE AND SYNERGISM IN STREPTOMYCIN AND PENICILLIN' MORTON ELEIN AND LEONARD J. KIMMELMAN Department of Bacteriology, School of Medicine, University

More information

Rutgers University, New Brunswick, N. J.) All these cultures proved to be highly active against mycobacteria.

Rutgers University, New Brunswick, N. J.) All these cultures proved to be highly active against mycobacteria. NEOMYCIN-PRODUCTION AND ANTIBIOTIC PROPERTIES 1, 2 3 By SELMAN A. WAKSMAN, HUBERT A. LECHEVALIER, AND DALE A. HARRIS (From the Department of Microbiology, New Jersey Agricultural Experiment Station, Rutgers

More information

Veterinary Microbiology ( ) Systemic mycoses 1 Dimorphic fungi รศ.สพ.ญ.อรวรรณ นว ภาพ ภาคว ชาจ ลช วว ทยา คณะส ตวแพทยศาสตร จ ฬาลงกรณ มหาว ทยาล ย

Veterinary Microbiology ( ) Systemic mycoses 1 Dimorphic fungi รศ.สพ.ญ.อรวรรณ นว ภาพ ภาคว ชาจ ลช วว ทยา คณะส ตวแพทยศาสตร จ ฬาลงกรณ มหาว ทยาล ย Veterinary Microbiology (3110301) Systemic mycoses 1 Dimorphic fungi รศ.สพ.ญ.อรวรรณ นว ภาพ ภาคว ชาจ ลช วว ทยา คณะส ตวแพทยศาสตร จ ฬาลงกรณ มหาว ทยาล ย 2547 Systemic mycoses แบ งเป น 3 group 1. เก ดจาก true

More information

Immunological Procedure for the Rapid and Specific

Immunological Procedure for the Rapid and Specific JOURNAL OF CUNICAL MICROBIOLOGY, Feb. 1977, p. 149-153 Copyright 0 1977 American Society for Microbiology Vol. 5, No. 2 Printed in U.S.A. Immunological Procedure for the Rapid and Specific Identification

More information

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection. 1. NAME OF THE MEDICINAL PRODUCT Nystatin Orifarm, 100 000 IU/ml oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 000 IU nystatin. Excipients with known effect: - Methyl parahydroxybenzoate

More information

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin

More information

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3 Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University Tae-yoon Choi ABSTRACT BACKGROUND: The use of disinfectants

More information

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED

More information

TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya

TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya 16 THE JOURNAL OF ANTIBIOTICS JAN. 1972 TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya Biological Research Laboratories, Research

More information

Principles of Antimicrobial therapy

Principles of Antimicrobial therapy Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur... SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT WONDERCEF powder and solvent for solution for injection for horses not intended for the production of foods for human consumption.

More information

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.1 INTRODUCTION Microorganisms that cause infectious disease are called pathogenic microbes. Although

More information

METRIGUARD. Technical Bulletin

METRIGUARD. Technical Bulletin METRIGUARD Technical Bulletin Metriguard is a general purpose disinfectant intended for use in cleaning, decontaminating and disinfecting equipment surfaces and non-critical instruments in hospitals, laboratories,

More information

Observations on the Mode of Action of Antibiotic Synergism and Antagonism

Observations on the Mode of Action of Antibiotic Synergism and Antagonism Antibiotics and other compounds. The substances tested were : (a) chlortetracycline hydrochloride (aureomycin, Lederle) in freshly prepared solution, and in a form partially inactivated by heating 200

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Malaseb shampoo for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substances: Chlorhexidine

More information

The goal of teaching:

The goal of teaching: The goal of teaching: 1. The morphology and biology of the fungi Classification of medically important fungi Fungal morphology and structure Antifungal (AF) - Mechanisms of action Fungi - biology and physiology

More information

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities International Journal of Microbiology and Allied Sciences (IJOMAS) ISSN: 2382-5537 May 2016, 2(4):22-26 IJOMAS, 2016 Research Article Page: 22-26 Isolation of antibiotic producing Actinomycetes from soil

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

Antibacterial Agents & Conditions. Stijn van der Veen

Antibacterial Agents & Conditions. Stijn van der Veen Antibacterial Agents & Conditions Stijn van der Veen Antibacterial agents & conditions Antibacterial agents Disinfectants: Non-selective antimicrobial substances that kill a wide range of bacteria. Only

More information

Chapter 8 Antimicrobial Activity of Callus Extracts of Justicia adhatoda L. in Comparison with Vasicine

Chapter 8 Antimicrobial Activity of Callus Extracts of Justicia adhatoda L. in Comparison with Vasicine Chapter 8 Antimicrobial Activity of Callus Extracts of Justicia adhatoda L. in Comparison with Vasicine 8.1. ABSTRACT The present work ascertain the antimicrobial activity of methanolic extracts of callus

More information

Antibacterial susceptibility testing

Antibacterial susceptibility testing Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several

More information

Name(s): Period: Date:

Name(s): Period: Date: Evolution in Action: Antibiotic Resistance HASPI Medical Biology Lab 21 Background/Introduction Evolution and Natural Selection Evolution is one of the driving factors in biology. It is simply the concept

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information

suis. The multiple amino acid media devised by these workers (KBD and MMHRB) contained cystine and methionine as organic sources of sulfur.

suis. The multiple amino acid media devised by these workers (KBD and MMHRB) contained cystine and methionine as organic sources of sulfur. THE CULTIVATION OF BRUCELLAE ON CHEMICALLY DEFINED MEDIA L. J. RODE, GLENDA OGLESBY, AND V. T. SCHUHARDT The Brucellosis Research Laboratory of the Clayton Foundation and the Department of Bacteriology,

More information

CAVICIDE1. Technical Bulletin

CAVICIDE1. Technical Bulletin CAVICIDE1 Technical Bulletin CaviCide1 is a multi-purpose disinfectant intended for use in cleaning, decontaminating and disinfecting hard non-porous, inanimate surfaces and non-critical instruments in

More information

Controlling Bacterial Growth

Controlling Bacterial Growth Pre- Lab Discussion: Controlling Bacterial Growth Most bacteria (and other microorganisms) are harmless. In fact, many bacteria are beneficial. Cheesemaking, decay, and soil building are a few of the important

More information

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How

More information

STANCES. VIII. PRODUCTION OF A GRISEIN-LIKE ANTI-

STANCES. VIII. PRODUCTION OF A GRISEIN-LIKE ANTI- 232 BACTERIOLOGY: GARSON AND WAKSMAN PROC. N. A. S. Two points are of particular interest. The first is the independent confirnation of Lederberg and Tatum's demonstration of regular recombination in E.

More information

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016 Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

Antimicrobial agents. are chemicals active against microorganisms

Antimicrobial agents. are chemicals active against microorganisms Antimicrobial agents are chemicals active against microorganisms Antibacterial Agents Are chemicals active against bacteria Antimicrobials Antibacterial Antifungal Antiviral Antiparasitic: -anti protozoan

More information

Overview. There are commonly found arrangements of bacteria based on their division. Spheres, Rods, Spirals

Overview. There are commonly found arrangements of bacteria based on their division. Spheres, Rods, Spirals Bacteria Overview Bacteria live almost everywhere. Most are microscopic ranging from 0.5 5 m in size, and unicellular. They have a variety of shapes when viewed under a microscope, most commonly: Spheres,

More information

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug

More information

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria

More information

GENTAMICIN: ACTIVITY IN VITRO AGAINST GRAMNEGATIVE ORGANISMS AND CLINICAL EXPERIENCES IN THE TREATMENT OF URINARY TRACT INFECTIONS

GENTAMICIN: ACTIVITY IN VITRO AGAINST GRAMNEGATIVE ORGANISMS AND CLINICAL EXPERIENCES IN THE TREATMENT OF URINARY TRACT INFECTIONS 390 CHEMOTHERAPY JULY 1967 GENTAMICIN: ACTIVITY IN VITRO AGAINST GRAMNEGATIVE ORGANISMS AND CLINICAL EXPERIENCES IN THE TREATMENT OF URINARY TRACT INFECTIONS M. OHOKOSHI*, Y. NAIDE, T. KAWAMURA, K. SUZUKI,

More information

A solution for current veterinary challenges

A solution for current veterinary challenges A solution for current veterinary challenges 2 www.jakmarketing.co.uk Introduction The current disease challenge in veterinary practices is increasingly coming from pathogens that are resistant to both

More information

Gye and Cramer (1919) found that the ionizable salts of calcium injected together with the washed spores of Cl. tetani or of certain

Gye and Cramer (1919) found that the ionizable salts of calcium injected together with the washed spores of Cl. tetani or of certain STUDIES ON TETANUS TOXOID III. ANTITOXIC RESPONSE IN GUINEA PIGS IMMUNIZED WITH TETANUS ALUM-PRECIPITATED TOXOID FOLLOWED BY TET- ANUS SPORES F. G. JONES AND W. A. JAMIESON Lilly Research Laboratories,

More information

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified

More information

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS

More information

Antibiotic Resistance

Antibiotic Resistance Antibiotic Resistance ACVM information paper Background Within New Zealand and internationally, concerns have been raised about an association between antibiotics used routinely to protect the health of

More information

HUMAN-PATHOGENIC FUNGI IN THE SOILS OF CENTRAL OHIO 12

HUMAN-PATHOGENIC FUNGI IN THE SOILS OF CENTRAL OHIO 12 No. COMMON GRACKLE IN NORTHERN OHIO 9 HUMANPATHOGENIC FUNGI IN THE SOILS OF CENTRAL OHIO P. V. KURUP AND J. A. SCHMITT College of Biological Sciences, The Ohio State University, Columbus, Ohio 0 ABSTRACT

More information

Susceptibility Testing

Susceptibility Testing APPLIED MICROBIOLOGY, Nov. 1969, p. 766-770 Copyright 1969 American Society for Microbiology Vol. 18, No. 5 Printed in U.S.A. Effect of Mixed Cultures on Antibiotic Susceptibility Testing AZRA SHAHIDI

More information

Testing Soil Microbes for Antibiotic Production

Testing Soil Microbes for Antibiotic Production http://www.coplac.org/publications/metamorphosis/ Testing Soil Microbes for Antibiotic Production Lauren Atkinson and Barbara Murdoch Dept. of Biology, Eastern Connecticut State University, Science Building,

More information

Biochrom AG s antibiotics solutions: working concentration. Biochrom AG Information, November 19, 2010

Biochrom AG s antibiotics solutions: working concentration. Biochrom AG Information, November 19, 2010 Biochrom AG s antibiotics solutions: Up-to to-date overview regarding of action, performance and working concentration Biochrom AG Information, November 19, 2010 Cell culture media allow not only cells

More information

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1 Mastitis and On-Farm Milk Cultures - A Field Study - Part 1 This two-part article discusses the results of a research project undertaken by Dr. Tim Olchowy, Senior Lecturer in Livestock Medicine, School

More information

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.

More information

Medical bacteriology Lecture 8. Streptococcal Diseases

Medical bacteriology Lecture 8. Streptococcal Diseases Medical bacteriology Lecture 8 Streptococcal Diseases Streptococcus agalactiae Beat haemolytic Lancifield group B Regularly resides in human vagina, pharynx and large inine Can be transferred to infant

More information

Antimicrobial Susceptibility Testing of Dermatophytes Comparison of the Agar Macrodilution and Broth Microdilution Tests

Antimicrobial Susceptibility Testing of Dermatophytes Comparison of the Agar Macrodilution and Broth Microdilution Tests Microbiology Chemotherapy 1998;44:31 35 M. Niewerth a V. Splanemann a H.C. Korting b J. Ring c D. Abeck a, c a Hautklinik des Universitätskrankenhauses Eppendorf, Hamburg, b Dermatologische Klinik und

More information

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING Pages with reference to book, From 94 To 97 S. Hafiz, N. Lyall, S. Punjwani, Shahida Q. Zaidi ( Department of Microbiology, The Aga Khan University

More information

HardyCHROM MRSA, Contact Plate

HardyCHROM MRSA, Contact Plate HardyCHROM MRSA, Contact Plate Cat. no. P14 HardyCHROM MRSA, Contact Plate, 15ml 10 plates/bag INTENDED USE HardyCHROM MRSA, Contact Plate is a chromogenic medium recommended for use in the cultivation

More information

Vet Integr Sci Veterinary Integrative Sciences. Types of dermatophyte on rabbit skin in rabbit cafés in Chiang Mai province

Vet Integr Sci Veterinary Integrative Sciences. Types of dermatophyte on rabbit skin in rabbit cafés in Chiang Mai province Research article Veterinary Integrative Science 2018; 16(3): XX-XX. Vet Integr Sci Veterinary Integrative Sciences ISSN; 2629-9968 (online) Website; www.vet.cmu.ac.th/cmvj Types of dermatophyte on rabbit

More information

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1975, p. 421-425 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 4 Printed in U.S.A. Effects of Minocycline and Other s on Fusobacterium necrophorum

More information

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion

More information

General Approach to Infectious Diseases

General Approach to Infectious Diseases General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor

More information

Quad Plate User s Manual

Quad Plate User s Manual A part of Eurofins DQCI SSGN - SSGNC Mastitis Culture Quad Plate User s Manual Eurofins Microbiology Laboratories / Eurofins DQCI Services 5205 Quincy Street, Mounds View, MN 55112 P: 763-785-0485 F: 763-785-0584

More information

Microbiology ( Bacteriology) sheet # 7

Microbiology ( Bacteriology) sheet # 7 Microbiology ( Bacteriology) sheet # 7 Revision of last lecture : Each type of antimicrobial drug normally targets a specific structure or component of the bacterial cell eg:( cell wall, cell membrane,

More information

CAUTION Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.

CAUTION Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. LINCOCIN- lincomycin hydrochloride injection, solution Pharmacia and Upjohn Company ---------- Lincocin lincomycin hydrochloride tablets and liquid lincomycin injection, USP For Use in Animals Only For

More information

Gram-positive cocci Staphylococci and Streptococcia

Gram-positive cocci Staphylococci and Streptococcia Medical microbiology Laboratory Lab 8 Gram-positive cocci Staphylococci and Streptococcia Lecturer Maysam A Mezher Gram positive cocci 1-Staphylococcus. 2-Streptococcus. 3-Micrococcus The medically important

More information

NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE. J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE and G. H.

NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE. J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE and G. H. 46 THE JOURNAL OF ANTIBIOTICS APR. 1976 NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE a G. H. WARREN Research Division, Wyeth Laboratories,

More information

Antibiotic Resistance in Bacteria

Antibiotic Resistance in Bacteria Antibiotic Resistance in Bacteria Electron Micrograph of E. Coli Diseases Caused by Bacteria 1928 1 2 Fleming 3 discovers penicillin the first antibiotic. Some Clinically Important Antibiotics Antibiotic

More information

ASSESSMENT OF COMMONLY AVAILABLE ANTIMICROBIAL AGENTS. A STUDY FROM ILALA-TANZANIA.

ASSESSMENT OF COMMONLY AVAILABLE ANTIMICROBIAL AGENTS. A STUDY FROM ILALA-TANZANIA. ASSESSMENT OF COMMONLY AVAILABLE ANTIMICROBIAL AGENTS. A STUDY FROM ILALA-TANZANIA. By: Malaika Paul (B.PHARM4, MUHAS-2008/2009) ABSTRACT Objective Microbiological assessment of commonly available antimicrobial

More information

n Am I B I A U n IVE RS ITV OF SCIEnCE AnD TECH n 0 LOGY

n Am I B I A U n IVE RS ITV OF SCIEnCE AnD TECH n 0 LOGY n Am I B I A U n IVE RS ITV OF SCIEnCE AnD TECH n 0 LOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES QUALIFICATION: BACHELOR OF BIOMEDICAL SCIENCES QUALIFICATION CODE: SOBBMS LEVEL:

More information

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus TEST REPORT TEST TYPE: Liquid Suspension Time Kill Study -Quantitative Test Based On ASTM 2315 TEST METHOD of Colloidal Silver Product at Contact time points: 30 sec, 1 min, 2 min, 5 min, 10 min, 15 min

More information

Visit ABLE on the Web at:

Visit ABLE on the Web at: This article reprinted from: Lessem, P. B. 2008. The antibiotic resistance phenomenon: Use of minimal inhibitory concentration (MIC) determination for inquiry based experimentation. Pages 357-362, in Tested

More information

Ringworm Fact Sheet What are ringworm? Who gets ringworm infections?

Ringworm Fact Sheet What are ringworm? Who gets ringworm infections? What are ringworm? Ringworm are types of fungi that cause common skin, hair and nail infections. Infections caused by these fungi are also known by the names tinea and ringworm. It is important to emphasize

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007 GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure

More information

Coccidioidomycosis in Dogs & Cats An Important Fungal Infection in Pets

Coccidioidomycosis in Dogs & Cats An Important Fungal Infection in Pets Coccidioidomycosis in Dogs & Cats An Important Fungal Infection in Pets Infectious organisms are everywhere. Bacteria, viruses, and fungi threaten our pets every day. Some prefer specific environmental

More information

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:

More information

For some reason the skin on the inside of both my nostrils continually splits, heals, and splits again. I do have allergies frequently

For some reason the skin on the inside of both my nostrils continually splits, heals, and splits again. I do have allergies frequently 12-3-2018 For some reason the skin on the inside of both my nostrils continually splits, heals, and splits again. I do have allergies frequently which may contribute. What is Folliculitis? Folliculitis

More information

6. STORAGE INSTRUCTIONS

6. STORAGE INSTRUCTIONS VRESelect 63751 A selective and differential chromogenic medium for the qualitative detection of gastrointestinal colonization of vancomycin-resistant Enterococcus faecium () and vancomycin-resistant Enterococcus

More information

Antimicrobials & Resistance

Antimicrobials & Resistance Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)

More information

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NUFLOR 300 mg/ml solution for injection for cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marbocare 20 mg/ml solution for injection for cattle and pigs (UK, IE, FR) Odimar 20 mg/ml solution for injection for cattle

More information

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1 Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination

More information

Antibiotics & Resistance

Antibiotics & Resistance What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information

The Aftermath of Penicillin

The Aftermath of Penicillin The Aftermath of Penicillin Introduction After the discovery of penicillin, a great deal of effort was begun to find other antibiotics. Thousands would be discovered. Most would be bacterial (Actinomycete)

More information

Microbiology: Practical Competence

Microbiology: Practical Competence Microbiology: Practical Competence Introduction Infectious diseases in animals are caused by the invasion of tissues by bacteria, especially the epithelium, by microorganisms. This invasion have many effects

More information

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija Microbiology : antimicrobial drugs Sheet 11 Ali abualhija return to our topic antimicrobial drugs, we have finished major group of antimicrobial drugs which associated with inhibition of protein synthesis

More information

Fujio Kobayashi, Takao Nagoya, Yoko Yoshimura, Kuniko Kaneko and Shin-ichi Ogata

Fujio Kobayashi, Takao Nagoya, Yoko Yoshimura, Kuniko Kaneko and Shin-ichi Ogata 128 THE JOURNAL OF ANTIBIOTICS FEB. 1972 STUDIES ON NEW ANTIBIOTIC LIVIDOMYCINS. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY OF LIVIDOMYCIN A Fujio Kobayashi, Takao Nagoya, Yoko Yoshimura, Kuniko Kaneko

More information

X-DISEASE TH. OF CATTLE I AYllG{ - OIS. ~I RCU lar 656 Extension Service in Agriculture and Home Economics INCE

X-DISEASE TH. OF CATTLE I AYllG{ - OIS. ~I RCU lar 656 Extension Service in Agriculture and Home Economics INCE X-DISEASE TH S INCE OF CATTLE I AYllG{ - OIS By C. C. MORRILL and R. P. LINK UIIJH8SITY OF lluuoij Coll ege of Veterinary Medicine and Agricultural Experiment Station 1941 A DISEASE OF CATTLE which is

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Genta 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances Gentamicin sulphate equivalent to Gentamicin

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AMPROLINE 400 mg/ml solution for use in drinking water for chickens and turkeys 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

MICRO-ORGANISMS by COMPANY PROFILE

MICRO-ORGANISMS by COMPANY PROFILE MICRO-ORGANISMS by COMPANY PROFILE 2017 1 SAPROPHYTES AND PATHOGENES SAPROPHYTES Not dangerous PATHOGENES Inducing diseases Have to be eradicated WHERE ARE THERE? EVERYWHERE COMPANY PROFILE 2017 3 MICROORGANISMS

More information

Author - Dr. Josie Traub-Dargatz

Author - Dr. Josie Traub-Dargatz Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary

More information

Distribution of thiabendazole and thiophanate-methyl resistant strains of Helminthosporium solani and Fusariurn sambucinum in Alberta potato storages

Distribution of thiabendazole and thiophanate-methyl resistant strains of Helminthosporium solani and Fusariurn sambucinum in Alberta potato storages Canadian Plant Disease Survey :, Distribution of thiabendazole and thiophanate-methyl resistant strains of Helminthosporium solani and Fusariurn sambucinum in Alberta potato storages J.D. Holleyl and L.M.

More information

SPECIMEN COLLECTION FOR CULTURE OF BACTERIAL PATHOLOGENS QUICK REFERENCE

SPECIMEN COLLECTION FOR CULTURE OF BACTERIAL PATHOLOGENS QUICK REFERENCE 1 Policy #: Subject: 611 (PLH-611-02) Effective Date: NA Reviewed Date: 2/1/2008 SPECIMEN COLLECTION FOR CULTURE OF BACTERIAL PATHOGENS QUICK REFERENCE Approved by: Laboratory Executive Director, Ed Hughes

More information

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram

More information